Stock CODX CO-DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Delayed Nasdaq
Other stock markets
 12:28:25 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.19 USD +7.21% Intraday chart for Co-Diagnostics, Inc. +3.48% -10.53%
Apr. 12 Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event CI
Apr. 04 Co-Diagnostics, Inc. Appoints Executive Appointments CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
CI
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
CI
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test
MT
Co-Diagnostics Shares Rise 21% After Submitting FDA Application For Covid-19 Test Platform
DJ
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
CI
Earnings Flash (CODX) CO-DIAGNOSTICS Reports Q3 Revenue $2.5M
MT
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
CI
Co-Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
CI
Co-Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Earnings Flash (CODX) CO-DIAGNOSTICS Posts Q2 Revenue $0.2M
MT
Co-Diagnostics, Inc. Announces Recent Grant Awards
CI
Co-Diagnostics, Inc. Receives Funding for Co-Dx PCR Home Platform from NIH RADx Tech Program
CI
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
CI
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Earnings Flash (CODX) CO-DIAGNOSTICS Posts Q1 Revenue $600,000
MT
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
CI
Co-Diagnostics, Inc. Initiates Clinical Evaluations for At-Home and Point-of-Care Co Dx PCR Home(TM) Platform
CI
Earnings Flash (CODX) CO-DIAGNOSTICS Reports Q3 Revenue $5.1M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CODX Stock
  4. News Co-Diagnostics, Inc.
  5. Highlights